MedPath

Patient-Centered Acupuncture for Pain (PCAP)

Completed
Conditions
Cancer Survivors
Interventions
Behavioral: Survey
Registration Number
NCT02152020
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Brief Summary

The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Women or men age 18 years or older
  • Primary diagnosis of cancer with history of stage I, II, or III cancer
  • Finished primary cancer treatments (surgery, chemotherapy, radiotherapy)
  • Have a Karnofsky score of 60 or greater
  • Can understand written English
  • Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week
  • Have been taking pain medications daily
  • Have had at least 15 days with pain in the preceding 30 days.
Exclusion Criteria
  • Women or men with metastatic (stage IV) cancer
  • Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks
  • Planned surgical procedures in the next 12 weeks
  • Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization
  • Women who are pregnant or breastfeeding
  • Unwillingness to adhere to study related procedures.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cancer survivorsSurvey-
Primary Outcome Measures
NameTimeMethod
Number of Adverse Events12 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Abramson Cancer Center of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath